ACTIVE SESSION TAPE Biotechnology $8M Cap Quant: HOLD

Why Is Genprex, Inc. (GNPX) Stock Down Today?

Updated Nov 22, 2026 7:10 AM ET ยท Prev Close $1.67

Pro Workspace
Last Session Price
$1.45 -13.17%
-$0.22 vs $1.67 prior close
Intraday Range
$1.45 โ€“ $1.67
Open $1.64
Relative Volume
0.77x Avg
92,984 sh
52-Week Range
$1.45 โ€“ $9.99
Benchmark Alpha
-9.53% vs SPY
-7.50% vs QQQ
20-Session Trend -19.9%

Session Regime & Catalyst Assessment

68% Signal Conviction
TECHNICAL 68% Driver Weight

Genprex, Inc. Pulling Back 13.17% on 0.77x Relative Volume

Genprex, Inc. (GNPX) is pulling back 13.17% (-$0.22) to $1.45 on 0.77x average session volume. Relative to benchmarks, GNPX is lagging the S&P 500 by -9.53%. 14-day RSI stands at 26.6, keeping momentum in a oversold regime.

NEWS 70% Weight
Genprex Presents Preclinical Data Identifying TROP2 as a Potential Predictive Biomarker for Reqorsa Gene Therapy in Lung Cancer

Genprex, Inc. Genprex or the Company Nasdaq Gnpx , a clinical-stage biotechnology company developing gene therapies designed to restore tumor-suppressor function in cancer and insulin-producing function in diabetes, toda

TECHNICAL 68% Weight
Moving Average Structure: Bearish Alignment

Price ($1.45) trades relative to 20-day SMA ($2.00) and 50-day SMA ($2.48).

Volume Confirmation
LOW VOLUME (0.77x) Consolidation
Sub-average participation โ€” monitor RVOL expansion above 1.2x.
Composite Catalyst Confidence 68%
Cross-checked across volume tape, benchmark alpha, options flow, and news.

Market & Sector Relative Strength

GNPX lagging the S&P 500 by -9.53%
GNPX Session
-13.17%
$1.45
S&P 500 (SPY)
-3.64%
$689.81
Nasdaq 100 (QQQ)
-5.67%
$608.45
Healthcare (XLV)
-0.12%
$177.24
Alpha vs SPY: -9.53% Alpha vs QQQ: -7.50% Alpha vs XLV: -13.05%

Options Flow & Execution Desk

Recent GNPX Catalyst Headlines

Verified Wire

1โ€“3 Day Expected Range & Key Level

48% Follow-Through
Lower Bound
$1.37
Short-term support band
Upper Bound
$1.53
Short-term resistance band
Key Inflection Level
$1.45 (session support)

Monitor volume expansion above 1.5x RVOL around $1.45 (session support) for directional breakout confirmation.

Technical Regime (GNPX)

BEARISH MA TREND
RSI (14)
26.6
Oversold
20-Day SMA
$2.00
Below 20d
50-Day SMA
$2.48
Below 50d
MACD Signal
Bearish
MACD -0.22
ADX (14)
24.1
Moderate trend
10d Momentum
-0.62
Soft 10-day momentum

Retail & Crowd Sentiment

Neutral
24h Messages
0
7d avg 0.9
Bullish / Bearish
0.0% / 0.0%
None buzz
Crowd Discussion Digest

Bearish sentiment prevails on StockTwits regarding $GNPX with no new information from Yahoo Finance news.

Reddit communities: 1 comment (Neutral)

About Genprex, Inc.

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System โ€ฆ

Sector
Healthcare
Market Cap
$8M
Employees
15

Get Instant GNPX Catalyst Alerts

Receive an email alert when GNPX triggers an unusual volume breakout, options sweep, or rating shift.

GNPX Session & Catalyst FAQ

Why is GNPX stock down today?

Genprex, Inc. (GNPX) is pulling back 13.17% (-$0.22) to $1.45 on 0.77x average session volume. Relative to benchmarks, GNPX is lagging the S&P 500 by -9.53%. 14-day RSI stands at 26.6, keeping momentum in a oversold regime.

Is GNPX stock a buy or sell right now?

Today's session carries a 68% catalyst conviction score on 0.77x relative volume (low participation). Our multi-factor model currently rates GNPX as HOLD. Review full valuation, quality, and timing signals on the GNPX Buy or Sell Decision Brief โ†’

What is GNPX's intrinsic value and expected trading range?

At $1.45, GNPX's modeled 1-to-3 session range is $1.37 โ€“ $1.53, with a key inflection level at $1.45 (session support). Compare current price against multi-year cash flow projections in the GNPX Intrinsic Value & DCF Model โ†’ and Market Cycle Phase Tracker โ†’

What do RSI and moving averages signal for GNPX?

RSI at 26.6 indicates oversold conditions โ€” watch for mean-reversion support. GNPX trades at $1.45 relative to its 20-day SMA ($2.00) and 50-day SMA ($2.48), reflecting a bearish moving-average structure.

Tradestie Flagship Research & Market Hubs